Zosano Pharma Corp (ZSAN):企業の財務・戦略的SWOT分析

◆英語タイトル:Zosano Pharma Corp (ZSAN) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14721
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Zosano Pharma Corp (Zosano Pharma), formerly ZP Holdings Inc, is a clinical stage biopharmaceutical company that develops proprietary transdermal delivery system. The company develops a transdermal microneedle patch system to deliver its drug formulations through the skin for the treatment of a variety of indications. Its microneedle patch system offers consistent drug delivery and improved ease of use and room-temperature stability. Zosano Pharma’s lead product candidate, ADAM Zolmitriptan (M207), is a drug which is used orally and nasally to treat acute migraine. The company works in partnership with other contract manufacturing organizations for clinical and commercial development of its products. Zosano Pharma is headquartered in Fremont, California, the US.

Zosano Pharma Corp Key Recent Developments

Nov 14,2018: Zosano Pharma reports third quarter 2018 financial results and operational update
Oct 16,2018: Zosanoa Pharma names new chief financial officer
Aug 09,2018: Zosano Pharma reports second quarter 2018 financial results and operational update
May 15,2018: Zosano Pharma Announces First Quarter 2018 Financial Results
Mar 12,2018: Zosano Pharma Announces Fourth Quarter and Fiscal Year 2017 Financial Results

This comprehensive SWOT profile of Zosano Pharma Corp provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Zosano Pharma Corp including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Zosano Pharma Corp – Key Information
Zosano Pharma Corp – Overview
Zosano Pharma Corp – Key Employees
Zosano Pharma Corp – Key Employee Biographies
Zosano Pharma Corp – Key Operational Heads
Zosano Pharma Corp – Major Products and Services
Zosano Pharma Corp – History
Zosano Pharma Corp – Company Statement
Zosano Pharma Corp – Locations And Subsidiaries
Zosano Pharma Corp – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Zosano Pharma Corp – Business Description
Zosano Pharma Corp – Corporate Strategy
Zosano Pharma Corp – SWOT Analysis
SWOT Analysis – Overview
Zosano Pharma Corp – Strengths
Zosano Pharma Corp – Weaknesses
Zosano Pharma Corp – Opportunities
Zosano Pharma Corp – Threats
Zosano Pharma Corp – Key Competitors

Section 3 – Company Financial Performance Charts

Zosano Pharma Corp – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Zosano Pharma Corp, Key Information
Zosano Pharma Corp, Key Ratios
Zosano Pharma Corp, Share Data
Zosano Pharma Corp, Major Products and Services
Zosano Pharma Corp, History
Zosano Pharma Corp, Key Employees
Zosano Pharma Corp, Key Employee Biographies
Zosano Pharma Corp, Key Operational Heads
Zosano Pharma Corp, Other Locations
Zosano Pharma Corp, Subsidiaries
Zosano Pharma Corp, Key Manufacturing facilities
Zosano Pharma Corp, Key Competitors
Zosano Pharma Corp, SWOT Analysis
Zosano Pharma Corp, Ratios based on current share price
Zosano Pharma Corp, Annual Ratios
Zosano Pharma Corp, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Zosano Pharma Corp, Performance Chart
Zosano Pharma Corp, Ratio Charts

★海外企業調査レポート[Zosano Pharma Corp (ZSAN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ONGC Videsh Ltd:企業のM&A・事業提携・投資動向
    ONGC Videsh Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ONGC Videsh Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • NanoString Technologies Inc (NSTG):企業の財務・戦略的SWOT分析
    Summary NanoString Technologies Inc (NanoString) is a developer of life science tools for translational research and molecular diagnostics. The company offers products such as sprint profiler, Dx analysis system with flex, nCounter MAX analysis system, protein assays, solid tumor assays, gene fusion …
  • VWR International LLC-医療機器分野:企業M&A・提携分析
    Summary VWR International LLC (VWR), a subsidiary of VWR Corp is a medical device company that offers healthcare equipment. The company’s products comprise adhesive dispensers, adhesive labels, adhesive slides, agarose and acrylamide, air freshener dispensers, air regulation valves, aluminum foil, a …
  • The Vanguard Group Inc:企業の戦略的SWOT分析
    The Vanguard Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Novartis Pharmaceuticals Corp:企業のM&A・事業提携・投資動向
    Novartis Pharmaceuticals Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Novartis Pharmaceuticals Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • American Dental Partners Inc:企業の戦略的SWOT分析
    American Dental Partners Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Luye Pharma Group Co Ltd (2186):製薬・医療:M&Aディール及び事業提携情報
    Summary Luye Pharma Group Co Ltd (Luye Pharma) is a pharmaceutical company that develops, produces and markets pharmaceutical products in the therapeutic areas of oncology, cardiovascular, metabolism and central nervous system. The company’s products include sodium aescinate for injection, xuezhikan …
  • Sobeys Inc:戦略・SWOT・企業財務分析
    Sobeys Inc - Strategy, SWOT and Corporate Finance Report Summary Sobeys Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Barrick Gold Corporation:戦略・SWOT・企業財務分析
    Barrick Gold Corporation - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Acorn Energy Inc (ACFN):石油・ガス:M&Aディール及び事業提携情報
    Summary Acorn Energy Inc (Acorn) is an energy technology holding company which operates electricity delivery, emergency back-up power generation, and remote monitoring and control systems through its subsidiaries. The company develops and produces sonar systems for the defense, HLS, energy and comme …
  • WEX Inc (WEX):企業の財務・戦略的SWOT分析
    WEX Inc (WEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Banco Bradesco S.A.:企業のM&A・事業提携・投資動向
    Banco Bradesco S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco Bradesco S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • IBIDEN CO., LTD.:企業の戦略・SWOT・財務情報
    IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report Summary IBIDEN CO., LTD. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Unigroup Inc
    Unigroup Inc - Strategy, SWOT and Corporate Finance Report Summary Unigroup Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Dova Pharmaceuticals Inc (DOVA)-製薬・医療分野:企業M&A・提携分析
    Summary Dova Pharmaceuticals Inc (Dova) is a clinical-stage pharmaceutical company that develops therapies for the treatment of orphan diseases. The company’s lead candidate, Avatrombopag (AVA), a novel, oral thrombopoietin receptor agonist, is under development for the treatment of thrombocytopenia …
  • Asahi Kasei Corp (3407)-製薬・医療分野:企業M&A・提携分析
    Summary Asahi Kasei Corp (Asahi Kasei), formerly Asahi Chemical Industry Co. Ltd., manufactures, processes, and sells chemical products. It is a holding company of Asahi Kasei Group. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation …
  • Atria Plc:戦略・SWOT・企業財務分析
    Atria Plc - Strategy, SWOT and Corporate Finance Report Summary Atria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Provectus Biopharmaceuticals Inc (PVCT):医療機器:M&Aディール及び事業提携情報
    Summary Provectus Biopharmaceuticals Inc (Provectus) is a developer of pharmaceuticals for oncology and dermatology indications. The company provides pipeline products such as PV-10 for locally advanced cutaneous melanoma, PV-10 for metastatic liver cancer and PV-10 for neuroendocrine tumors [NET], …
  • Nanjing Pharmaceutical Co Ltd (600713):企業の財務・戦略的SWOT分析
    Nanjing Pharmaceutical Co Ltd (600713) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Sinclairs Hotels Limited:企業の戦略・SWOT・財務情報
    Sinclairs Hotels Limited - Strategy, SWOT and Corporate Finance Report Summary Sinclairs Hotels Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆